Although the prior reports show QF conversion rate to be between 7%~ 18% in TNF-blockers users in psoriasis [17–20], the 7.3% percent is still lower than the experience of TNF blockers for psoriasis in Taiwan [16]. The gene discussed is TNF; the disease is psoriasis.